Janey Phipps
Family · London, KYNPI 1245328319
Payments from drug & device makers
Across 301 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$817
- Novo Nordisk$777
- Lilly USA, LLC$490
- Biohaven Pharmaceuticals, Inc.$335
- Abbott$330
- Biohaven Pharmaceutical Holding Company Ltd.$300
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,275100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $817 |
| Novo Nordisk | 52 | $777 |
| Lilly USA, LLC | 35 | $490 |
| Biohaven Pharmaceuticals, Inc. | 9 | $335 |
| Abbott | 11 | $330 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $300 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $253 |
| Novartis | 13 | $241 |
| Pfizer | 20 | $226 |
| Bayer | 11 | $178 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| Johnson & Johnson | 10 | $155 |
| Phathom Pharmaceuticals, Inc. | 7 | $146 |
| Amgen | 9 | $136 |
| GSK | 7 | $101 |
| Si-bone, Inc. | 1 | $99 |
| Amarin Pharma, Inc. | 6 | $85 |
| Astellas Pharma US Inc | 4 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Ardelyx, Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Merck | 2 | $32 |
| Mylan Specialty L.p. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Gilead | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Sanofi | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$339
- CARDIOMEMS$141
- Auvelity$125
How this compares
$5,295 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 74 | $90,251 |
| OzempicSemaglutide | 80 | $89,297 |
| JardianceEmpagliflozin | 52 | $46,487 |
| TrulicityDulaglutide | 31 | $37,855 |
| EliquisApixaban | 34 | $31,289 |
| Tresiba Flextouch U-100Insulin Degludec | 30 | $25,084 |
| LinzessLinaclotide | 17 | $16,435 |
| TradjentaLinagliptin | 16 | $15,931 |
| FarxigaDapagliflozin Propanediol | 27 | $15,531 |
| JanuviaSitagliptin Phosphate | 20 | $15,280 |
| Ondansetron Hcl | 54 | $12,580 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $10,887 |
| XareltoRivaroxaban | 13 | $10,666 |
| GemtesaVibegron | 13 | $7,397 |
| MovantikNaloxegol Oxalate | 15 | $6,713 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $490 | $128,105105 claims |
| Novo NordiskOzempic | $777 | $89,29780 claims |
| PfizerEliquis | $226 | $31,28934 claims |
| AstraZenecaFarxiga, Symbicort | $15 | $20,16947 claims |
| AbbVieLinzess, Synthroid | $817 | $18,49646 claims |
| MerckJanuvia | $32 | $15,28020 claims |
| GSKBreo Ellipta | $101 | $10,88727 claims |
| Johnson & JohnsonXarelto | $155 | $10,66613 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $46 | $7,39713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in London
- Robin HouseLondon$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.